https://www.pharmanow.live/latest-news/mankind-pharma-appoints-sandeep-joshi-avp-international-business 2026-08-19T22:03:06+05:30 Pharma Now en 2026-08-19T00:00:00+05:30 Mankind Pharma Appoints Sandeep Joshi as Associate Vice President of International Business https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/9b5d2877-5f11-45b2-a005-d7bbda2945a2/2cc0f8f1-210f-422c-9be8-3b3e145e7731.png https://www.pharmanow.live/latest-news/gland-pharma-appoints-deepak-sapra-ceo-injectable-expansion 2026-08-19T22:02:22+05:30 Pharma Now en 2026-08-19T00:00:00+05:30 Gland Pharma Appoints Deepak Sapra as CEO Amid Global Injectable Expansion https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/9b5d2877-5f11-45b2-a005-d7bbda2945a2/4b454215-122f-4ce2-bd3d-bce2f3f86e02.png https://www.pharmanow.live/latest-news/teva-fda-priority-review-ecopipam-nda-pediatric-tourette-syndrome 2026-08-19T22:01:12+05:30 Pharma Now en 2026-08-19T00:00:00+05:30 Teva Gains FDA Priority Review for Ecopipam NDA Targeting Pediatric Tourette Syndrome https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/9b5d2877-5f11-45b2-a005-d7bbda2945a2/fb13dda7-5c24-411f-829b-b0ce719f4da4.png https://www.pharmanow.live/latest-news/fda-cber-potency-assessment-guidance-active-immunotherapy-cgt-products 2026-08-19T22:00:40+05:30 Pharma Now en 2026-08-19T00:00:00+05:30 FDA CBER Issues Potency Assessment Guidance for Active Immunotherapy CGT Products https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/9b5d2877-5f11-45b2-a005-d7bbda2945a2/8973b013-decc-4164-bdbd-3e30ea902de8.png https://www.pharmanow.live/latest-news/ideaya-biosciences-signs-clinical-collaboration-genentech-ide892-mtap-deleted-pdac 2026-08-19T21:57:10+05:30 Pharma Now en 2026-08-19T00:00:00+05:30 IDEAYA Biosciences Signs Clinical Collaboration with Genentech for IDE892 in MTAP-Deleted PDAC https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/d9571fe4-5037-4654-aacb-9f19486e3400/5b593956-6863-457c-a49f-49c05cd926c7.png https://www.pharmanow.live/latest-news/novartis-esc-2026-cardiovascular-abstracts-inclisiran-abelacimab 2026-08-19T15:17:54+05:30 Pharma Now en 2026-08-19T00:00:00+05:30 Novartis Presents 10 Cardiovascular Abstracts at ESC 2026, Including Phase IV Inclisiran and Abelacimab Data https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/2dbd8e7a-b3e0-43ea-ba0b-0b4e9347f8f8/23b9e905-26c6-4b8e-9387-9eb2b7e9db79.png https://www.pharmanow.live/latest-news/novartis-india-appoints-dr-chetan-p-head-medical-regulatory-pharmacovigilance 2026-08-19T12:43:26+05:30 Pharma Now en 2026-08-18T00:00:00+05:30 Novartis India Appoints Dr. Chetan P. as Head of Medical, Regulatory and Pharmacovigilance https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/NovartisIndiaAppointsDr.ChetanP.asHeadofMedical,RegulatoryandPharmacovigilance(1)20260819124300.png https://www.pharmanow.live/latest-news/hearzap-acquires-amplifon-india-hearing-healthcare-business 2026-08-19T11:41:02+05:30 Pharma Now en 2026-08-18T00:00:00+05:30 Hearzap Acquires Amplifon India's Hearing Healthcare Business in Strategic Consolidation Move https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/HearzapAcquiresAmplifonIndia'sHearingHealthcareBusinessinStrategicConsolidationMove20260819114053.png https://www.pharmanow.live/latest-news/tianjin-kilo-pharmaceutical-fda-warning-letter-704a4-remote-review-2026 2026-08-19T11:38:31+05:30 Pharma Now en 2026-08-18T00:00:00+05:30 Tianjin Kilo Pharmaceutical Receives FDA Warning Letter After Remote Records Review https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/image781720260819113827.png https://www.pharmanow.live/latest-news/safrel-pharmaceuticals-fda-warning-letter-quality-unit-otc-2026 2026-08-19T11:40:22+05:30 Pharma Now en 2026-08-18T00:00:00+05:30 Safrel Pharmaceuticals Receives FDA Warning Letter Citing Quality Unit Collapse Across OTC Drug Operations https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/4da5c123-0ba9-408b-8622-f8a1a7ebd6aa/5e47c87a-77de-485b-9501-f7570b1b00bb.png https://www.pharmanow.live/latest-news/propanc-biopharma-phase-1b-feasibility-assessment-prp-solid-tumors 2026-08-19T11:59:35+05:30 Pharma Now en 2026-08-18T00:00:00+05:30 Propanc Biopharma Initiates Feasibility Assessment for PRP in Advanced Solid Tumors https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/PropancBiopharmaInitiatesFeasibilityAssessmentforPRPinAdvancedSolidTumors20260819114258.png https://www.pharmanow.live/latest-news/fibrobiologics-chondrocyte-spheroids-cartilage-repair-preclinical-study 2026-08-19T11:41:52+05:30 Pharma Now en 2026-08-18T00:00:00+05:30 FibroBiologics Achieves Cartilage Repair in Preclinical Study Using Four-Day Chondrocyte Spheroid Process https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/4da5c123-0ba9-408b-8622-f8a1a7ebd6aa/66db15a2-87ec-48fb-a6f2-b447d5558c38.png https://www.pharmanow.live/latest-news/fda-public-comment-generative-ai-medical-device-regulation-2026 2026-08-19T11:39:51+05:30 Pharma Now en 2026-08-18T00:00:00+05:30 FDA Opens Public Comment on Generative AI Medical Device Regulation, Signaling Broader Framework Ahead https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/FDAOpensPublicCommentonGenerativeAIMedicalDeviceRegulation,SignalingBroaderFrameworkAhead20260819113943.png https://www.pharmanow.live/latest-news/biocon-fda-approval-yesintek-ustekinumab-prefilled-autoinjector-us 2026-08-19T11:39:21+05:30 Pharma Now en 2026-08-18T00:00:00+05:30 Biocon Gains FDA Approval for Yesintek Ustekinumab Prefilled Autoinjector in U.S. Market https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/BioconGainsFDAApprovalforYesintekUstekinumabPrefilledAutoinjectorinU.S.Market20260819113910.png https://www.pharmanow.live/latest-news/coultreon-biopharma-appoints-prista-charuworn-cmo-sik3-inhibitor-phase-ii 2026-08-19T11:42:42+05:30 Pharma Now en 2026-08-18T00:00:00+05:30 Coultreon Biopharma Appoints Prista Charuworn As CMO https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/CoultreonBiopharmaAppointsPristaCharuwornAsCMO20260819114234.png https://www.pharmanow.live/latest-news/biocon-fda-approval-yesintek-prefilled-autoinjectors-us-biosimilar 2026-08-18T13:23:58+05:30 Pharma Now en 2026-08-18T00:00:00+05:30 Biocon Wins FDA Nod for Yesintek Autoinjectors in US https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/BioconWinsFDANodforYesintekAutoinjectorsinUS20260818132354.png https://www.pharmanow.live/latest-news/fda-cdc-vaers-reporting-obligations-vaccine-manufacturers-post-market-surveillance 2026-08-18T13:25:28+05:30 Pharma Now en 2026-08-18T00:00:00+05:30 FDA, CDC Reaffirm Vaccine Manufacturers’ VAERS Reporting Duties https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/FDA,CDCReaffirmVaccineManufacturers’VAERSReportingDuties20260818132525.png https://www.pharmanow.live/latest-news/fda-cdc-vaers-mandatory-reporting-obligations-vaccine-manufacturers-ncvia 2026-08-18T13:23:38+05:30 Pharma Now en 2026-08-18T00:00:00+05:30 FDA & CDC Clarify VAERS Reporting Duties Under NCVIA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/818f8418-3b0c-422a-9e15-74d580b91f2c/50f54ed8-f99d-4c8b-917b-6f6e8ef0b42f.png https://www.pharmanow.live/latest-news/emergent-bidefense-fda-approval-cyfendus-anthrax-vaccine-animal-rule 2026-08-18T14:53:31+05:30 Pharma Now en 2026-08-18T00:00:00+05:30 Emergent BioDefense Gains FDA Nod For CYFENDUS Anthrax Vaccine https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/EmergentBioDefenseGainsFDANodForCYFENDUSAnthraxVaccine20260818145323.png https://www.pharmanow.live/latest-news/fda-hctp-electronic-registration-requirements-21-cfr-part-1271 2026-08-18T14:51:41+05:30 Pharma Now en 2026-08-18T00:00:00+05:30 FDA Reaffirms HCT/P E-Registration Rules for Tissue Establishments https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/PE-RegistrationRulesforTissueEstablishments20260818145135.png https://www.pharmanow.live/latest-news/fda-cber-ends-notarization-becats-biologics-export-certification 2026-08-18T13:24:28+05:30 Pharma Now en 2026-08-18T00:00:00+05:30 FDA Ends Export Certificate Notarization, Moves Biologics To BECATS https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/FDAEndsExportCertificateNotarization,MovesBiologicsToBECATS20260818132422.png https://www.pharmanow.live/latest-news/cber-advances-global-biologics-strategy-ich-apec-harmonization 2026-08-18T13:26:19+05:30 Pharma Now en 2026-08-18T00:00:00+05:30 CBER Advances Global Biologics Strategy Through ICH And APEC https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/CBERAdvancesGlobalBiologicsStrategyThroughICHAndAPEC20260818132609.png https://www.pharmanow.live/latest-news/optimus-pharma-dcgi-approval-tapinarof-cream-india 2026-08-19T14:27:43+05:30 Pharma Now en 2026-08-17T00:00:00+05:30 Optimus Pharma Gains First-in-India DCGI Approval for Tapinarof Cream 1% in Dermatology https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/c3e97afd-8fd6-42cb-8fb4-19ba5eb3c446/e5702a9c-c1a5-4fd2-b883-36cee3a6ea86.png https://www.pharmanow.live/latest-news/artelo-biosciences-secures-us-patent-allowance-art27-13-commercial-formulation-2041 2026-08-18T16:12:52+05:30 Pharma Now en 2026-08-17T00:00:00+05:30 Artelo Biosciences Secures U.S. Patent Allowance for ART27.13 Commercial Formulation Through 2041 https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/c3e97afd-8fd6-42cb-8fb4-19ba5eb3c446/ee84849c-4c83-4dff-97ab-2fe1077ab052.png https://www.pharmanow.live/latest-news/lupin-gains-us-fda-approval-generic-pitolisant-tablets-bioequivalent-wakix 2026-08-18T16:11:30+05:30 Pharma Now en 2026-08-17T00:00:00+05:30 Lupin Gains US FDA Approval for Generic Pitolisant Tablets Bioequivalent to Wakix https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/70281d53-88af-40b4-9910-0fc3490879a8/d5a0540e-31b4-42fb-8ca9-5888dd9830fd.png https://www.pharmanow.live/latest-news/johnson-johnson-secures-258b-option-acquire-sail-biomedicines-in-vivo-car-t 2026-08-18T16:12:01+05:30 Pharma Now en 2026-08-17T00:00:00+05:30 Johnson & Johnson Secures $2.58B Option to Acquire Sail Biomedicines for In Vivo CAR T Platform https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/70281d53-88af-40b4-9910-0fc3490879a8/f074c643-9994-4093-9baf-c6a140f1ce2f.png https://www.pharmanow.live/latest-news/telangana-merges-food-safety-drugs-control-tg-safe 2026-08-17T18:50:10+05:30 Pharma Now en 2026-08-17T00:00:00+05:30 Telangana Merges Food Safety and Drugs Control Departments https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/TelanganaMergesFoodSafetyandDrugsControlDepartments(1)20260817185003.png https://www.pharmanow.live/latest-news/sai-life-sciences-appoints-maneesh-pingle-president-discovery 2026-08-17T18:58:49+05:30 Pharma Now en 2026-08-17T00:00:00+05:30 Sai Life Sciences Appoints Maneesh Pingle as President of Discovery Division https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/SaiLifeSciencesAppointsManeeshPingleasPresidentofDiscoveryDivision20260817185303.png https://www.pharmanow.live/latest-news/modi-global-top-five-indian-pharma-compliance-bar 2026-08-17T18:51:11+05:30 Pharma Now en 2026-08-17T00:00:00+05:30 Modi Sets Global Top-Five Target for Indian Pharma, Raising the Compliance Bar https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/ModiSetsGlobalTop-FiveTargetforIndianPharma,RaisingtheComplianceBar(1)20260817185043.png https://www.pharmanow.live/latest-news/sun-pharma-us-court-ruling-lipitor-antitrust-litigation 2026-08-17T18:49:34+05:30 Pharma Now en 2026-08-17T00:00:00+05:30 Sun Pharma Secures US Court Ruling Dismissing Lipitor Antitrust Litigation https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/SunPharmaSecuresUSCourtRulingDismissingLipitorAntitrustLitigation20260817184923.png https://www.pharmanow.live/latest-news/aurobindo-vai-classification-raleigh-facility-form-483 2026-08-17T18:48:39+05:30 Pharma Now en 2026-08-17T00:00:00+05:30 Aurobindo Gains VAI Classification for Raleigh Facility After 11-Observation Form 483 https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/AurobindoGainsVAIClassificationforRaleighFacilityAfter11-ObservationForm48320260817184832.png https://www.pharmanow.live/latest-news/tcs-launches-agentic-ai-platform-drug-development-pharmacovigilance 2026-08-17T18:52:11+05:30 Pharma Now en 2026-08-17T00:00:00+05:30 TCS Launches Agentic AI Platform Targeting Drug Development & Pharmacovigilance Workflows https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/TCSLaunchesAgenticAIPlatformTargetingDrugDevelopment&PharmacovigilanceWorkflows20260817185158.png https://www.pharmanow.live/latest-news/cansinobio-nmpa-nda-acceptance-td5cp-adolescent-adult-pertussis-vaccine 2026-08-17T14:45:57+05:30 Pharma Now en 2026-08-17T00:00:00+05:30 CanSinoBIO Secures NMPA NDA Acceptance for Td5cp Adolescent & Adult Pertussis Vaccine https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/CanSinoBIOSecuresNMPANDAAcceptanceforTd5cpAdolescentandAdultPertussisVaccine20260817120110.png https://www.pharmanow.live/latest-news/abbott-india-appoints-dr-sudarshan-jain-chairman 2026-08-17T12:02:16+05:30 Pharma Now en 2026-08-17T00:00:00+05:30 Abbott India Appoints Dr. Sudarshan Jain as Chairman https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/FrAbbottIndiaAppointsDr.SudarshanJainasChairman20260817120209.png